Novel Flavaglines Displaying Improved Cytotoxicity-Reference-Cited by-同舟云学术

Novel Flavaglines Displaying Improved Cytotoxicity

Published:2010-12-13 Issue:1 Volume:54 Page:411-415
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Thuaud Frédéric¹,Ribeiro Nigel¹,Gaiddon Christian²,Cresteil Thierry³,Désaubry Laurent¹

Affiliation:

1. Therapeutic Innovation Laboratory (UMR 7200), Department of Medicinal Chemistry, Faculté de Pharmacie, CNRS−Université de Strasbourg, 74 Route du Rhin, BP 60024, 67401 Illkirch, France

2. Laboratoire de Signalisation et Neurodégénérescence (UMRS692), INSERM, Faculté de Médecine, Université de Strasbourg, 67085 Strasbourg, France

3. Institut de Chimie des Substances Naturelles (UPR 2301), CNRS, Bâtiment 27, Avenue de la Terrasse, 91198 Gif-sur-Yvette, France

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm101318b

Reference17 articles.

1. Potential of Cyclopenta[b]benzofurans from Aglaia Species in Cancer Chemotherapy

2. Chemistry and Biological Activity of Rocaglamide Derivatives and Related Compounds in Aglaia Species (Meliaceae)

3. Activity-guided isolation of cytotoxic constituents from the bark of Aglaia crassinervia collected in Indonesia

4. Flavaglines: A group of efficient growth inhibitors block cell cycle progression and induce apoptosis in colorectal cancer cells

5. The traditional Chinese herbal compound rocaglamide preferentially induces apoptosis in leukemia cells by modulation of mitogen-activated protein kinase activities

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-tumor effects of the eIF4A inhibitor didesmethylrocaglamide and its derivatives in human and canine osteosarcomas;Scientific Reports;2024-08-20

2. Anti-tumor Effects of the eIF4A Inhibitor Didesmethylrocaglamide and Its Derivatives in Human and Canine Osteosarcomas;2024-06-14

3. Design and Synthesis of Cytotoxic Water-Soluble Rocaglaol Derivatives against HEL Cells by Inhibiting Fli-1;Journal of Natural Products;2024-01-22

4. Halogenated Rocaglate Derivatives: Pan-antiviral Agents against Hepatitis E Virus and Emerging Viruses;Journal of Medicinal Chemistry;2023-12-21

5. Characterization of Plasmodium falciparum prohibitins as novel targets to block infection in humans by impairing the growth and transmission of the parasite;Biochemical Pharmacology;2023-06